Your browser doesn't support javascript.
loading
Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial.
Xu, Jia-Wei; Wang, Bu-Sen; Gao, Ping; Huang, Hai-Tao; Wang, Fei-Yu; Qiu, Wei; Zhang, Yuan-Yuan; Xu, Yu; Gou, Jin-Bo; Yu, Lin-Ling; Liu, Xuan; Wang, Rui-Jie; Zhu, Tao; Hou, Li-Hua; Wang, Qing-.
Afiliación
  • Xu JW; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, People's Republic of China.
  • Wang BS; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People's Republic of China.
  • Gao P; Logistics University of Chinese People's Armed Police Force, Tianjin, People's Republic of China.
  • Huang HT; CanSino Biologics Inc., Tianjin, People's Republic of China.
  • Wang FY; CanSino Biologics Inc., Tianjin, People's Republic of China.
  • Qiu W; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, People's Republic of China.
  • Zhang YY; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, People's Republic of China.
  • Xu Y; CanSino Biologics Inc., Tianjin, People's Republic of China.
  • Gou JB; CanSino Biologics Inc., Tianjin, People's Republic of China.
  • Yu LL; Expanded Program on Immunization, Yubei District Center for Disease Control and Prevention, Chongqing, People's Republic of China.
  • Liu X; CanSino Biologics Inc., Tianjin, People's Republic of China.
  • Wang RJ; CanSino Biologics Inc., Tianjin, People's Republic of China.
  • Zhu T; CanSino Biologics Inc., Tianjin, People's Republic of China.
  • Hou LH; Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, People's Republic of China.
  • Wang Q; Expanded Program on Immunization, Chongqing Center for Disease Control and Prevention, Chongqing, People's Republic of China.
Emerg Microbes Infect ; 13(1): 2281355, 2024 Dec.
Article en En | MEDLINE | ID: mdl-37933089
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Adult / Humans Idioma: En Revista: Emerg Microbes Infect Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Adult / Humans Idioma: En Revista: Emerg Microbes Infect Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos